메뉴 건너뛰기
Australian Prescriber
Volumn 29, Issue 3, 2006, Pages 76-79
Treatment of adult leukaemias
Author keywords

Antineoplastics; Imatinib; Stem cell transplantation
Indexed keywords

ALEMTUZUMAB; ALPHA INTERFERON; ANTHRACYCLINE; ARSENIC TRIOXIDE; BCR ABL PROTEIN; BUSULFAN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; HYDROXYUREA; IDARUBICIN; IMATINIB; PODOPHYLLOTOXIN; PREDNISOLONE; RETINOID; RITUXIMAB; VINCRISTINE;
EID: 33744778428     PISSN: 03128008     EISSN: 03128008     Source Type: Journal    
DOI: 10.18773/austprescr.2006.047     Document Type: Review
Times cited : (3)
References (7)
  • 2
    • 0034986918 scopus 로고    scopus 로고
    • Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia
    • Matthews JP, Bishop JF, Young GA, Juneja SK, Lowenthal RM, Garson OM, et al. Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia. Br J Haematol 2001;113:727-36.
    • (2001) Br J Haematol , vol.113 , pp. 727-736
    • Matthews, J.P.1    Bishop, J.F.2    Young, G.A.3    Juneja, S.K.4    Lowenthal, R.M.5    Garson, O.M.6
  • 3
    • 0034308663 scopus 로고    scopus 로고
    • Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia
    • Wang ZY, Chen Z. Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia. Lancet Oncol 2000;1:101-6.
    • (2000) Lancet Oncol , vol.1 , pp. 101-106
    • Wang, Z.Y.1    Chen, Z.2
  • 4
    • 10744233716 scopus 로고    scopus 로고
    • Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
    • IRIS Investigators
    • O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, et al. IRIS Investigators. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003;348:994-1004.
    • (2003) N Engl J Med , vol.348 , pp. 994-1004
    • O'Brien, S.G.1    Guilhot, F.2    Larson, R.A.3    Gathmann, I.4    Baccarani, M.5    Cervantes, F.6
  • 5
    • 0038518619 scopus 로고    scopus 로고
    • Practical management of patients with chronic myeloid leukemia receiving imatinib
    • Deininger MW, O'Brien SG, Ford JM, Druker BJ. Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol 2003;21:1637-47.
    • (2003) J Clin Oncol , vol.21 , pp. 1637-1647
    • Deininger, M.W.1    O'Brien, S.G.2    Ford, J.M.3    Druker, B.J.4
  • 6
    • 0033583824 scopus 로고    scopus 로고
    • Chemotherapeutic options in chronic lymphocytic leukemia: A meta-analysis of the randomized trials
    • CLL Trialists' Collaborative Group. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. J Natl Cancer Inst 1999;91:861-8.
    • (1999) J Natl Cancer Inst , vol.91 , pp. 861-868
  • 7
    • 0037522837 scopus 로고    scopus 로고
    • A high proportion of molecular remission can be obtained with a fludarabine, cyclophosphamide, rituximab combination (FCR) in chronic lymphocytic leukemia (CLL)
    • Keating MJ, Manshouri T, O'Brien S, Wierda W, Kantarjian H, Washington L, et al. A high proportion of molecular remission can be obtained with a fludarabine, cyclophosphamide, rituximab combination (FCR) in chronic lymphocytic leukemia (CLL). Blood 2002;100(Part 1):205a.
    • (2002) Blood , vol.100 , Issue.1 PART
    • Keating, M.J.1    Manshouri, T.2    O'Brien, S.3    Wierda, W.4    Kantarjian, H.5    Washington, L.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.